No-prescription birth-control pills? 4 things to know as FDA considers approval.


The Food and Drug Administration this week is weighing what would be a first-ever approval of a daily birth-control pill for use without a prescription — a step that could allow many more people to access the most commonly used reversible contraception method in the U.S., policy experts say. 

FDA advisory committees meeting jointly Tuesday and Wednesday will review an application submitted by drugmaker Perrigo PRGO to switch from prescription to over-the-counter availability for Opill, a daily contraceptive first approved…

This article was originally published by Read the original article here.

Previous article: EIA lowers its price forecasts for WTI and Brent oil
Next articleFA Center: Cramer ETF vs. Cramer: Shorting CNBC host’s stock picks hasn’t delivered the promised ratings


Please enter your comment!
Please enter your name here